Shi Hao,Lyu Zhibao,Chen Zhou.Efficacy and safety of doxycycline injection for marcocystic and mixed-cystic lymphatic malformations in children[J].Journal of Clinical Pediatric Surgery,,21():558-561.[doi:10.3760/cma.j.cn101785-202104014-011]
Click Copy

Efficacy and safety of doxycycline injection for marcocystic and mixed-cystic lymphatic malformations in children

References:

[1] Kulungowski AM, Patel M.Lymphatic malformations[J].Semin Pediatr Surg, 2020, 29(5):150971.DOI:10.1016/j.sempedsurg.2020.150971.
[2] 王燕妮, 齐鸿燕, 张学军.B超引导下微创负压抽吸技术治疗儿童肢体淋巴管畸形的疗效探讨[J].临床小儿外科杂志, 2019, 18(3):221-224.DOI:10.3969/j.issn.1671-6353.2019.03.012.Wang YN, Qi HY, Zhang XJ.Efficacy of mini-invasive negative pressure aspiration guided by B-ultrasound for limb lymphatic malformation in children[J].J Clin Ped Sur, 2019, 18(3):221-224.DOI:10.3969/j.issn.1671-6353.2019.03.012.
[3] Mimura H, Akita S, Fujino A, et al.Japanese Clinical Practice Guidelines for Vascular Anomalies 2017[J].Pediatr Int, 2020, 62(3):257-304.DOI:10.1111/ped.14077.
[4] 中华医学会整形外科分会血管瘤和脉管畸形学组.血管瘤和脉管畸形的诊断及治疗指南(2019版)[J].组织工程与重建外科杂志, 2019, 15(5):277-317.DOI:10.3969/j.issn.1673-0364.2019.05.001.Chinese Society for the Study of Vascular Anomalies (CSSVA).CSSVA Guidelines for Vascular Anomalies 2019[J].Journal of Tissue Engineering and Reconstructive Surgery, 2019, 15(5):277-317.DOI:10.3969/j.issn.1673-0364.2019.05.001.
[5] Burrows PE, Mitri RK, Alomari A, et al.Percutaneous sclerotherapy of lymphatic malformations with doxycycline[J].Lymphatic Research and Biology, 2008, 6(3-4):209-216.DOI:10.1089/lrb.2008.1004.
[6] Zamora AK, Barry WE, Nowicki D, et al.A multidisciplinary approach to management of abdominal lymphatic malformations[J].J Pediatr Surg, 2021, 56(8):1425-1429.DOI:10.1016/j.jpedsurg.2020.10.007.
[7] Bouwman FCM, Kooijman SS, Verhoeven BH, et al.Lymphatic malformations in children:treatment outcomes of sclerotherapy in a large cohort[J].Eur J Pediatr, 2021, 180(3):959-966.DOI:10.1007/s00431-020-03811-4.
[8] Luks VL, Kamitaki N, Vivero MP, et al.Lymphatic and other vascular malformative/overgrowth disorders are caused by somatic mutations in PIK3CA[J].J Pediatr, 2015, 166(4):1048-1054.DOI:10.1016/j.jpeds.2014.12.069.
[9] Fereydooni A, Dardik A, Nassiri N.Molecular changes associated with vascular malformations[J].J Vasc Surg, 2019, 70(1):314-326.e311.DOI:10.1016/j.jvs.2018.12.033.
[10] Molitch HI, Unger EC, Witte CL, et al.Percutaneous sclerotherapy of lymphangiomas[J].Radiology, 1995, 194(2):343-347.DOI:10.1148/radiology.194.2.7529933.
[11] Shaye DA, Burks CA, Gadkaree SK, et al.Self-compounded doxycycline sclerotherapy for the treatment of lymphatic malformations in low-resource settings[J].World J Surg, 2020, 44(11):3616-3619.DOI:10.1007/s00268-020-05667-z.
[12] Lee CZ, Xu B, Hashimoto T, et al.Doxycycline suppresses cerebral matrix metalloproteinase-9 and angiogenesis induced by focal hyperstimulation of vascular endothelial growth factor in a mouse model[J].Stroke, 2004, 35(7):1715-1719.DOI:10.1161/01.STR.0000129334.05181.b6.
[13] Wiegand S, Eivazi B, Zimmermann AP, et al.Sclerotherapy of lymphangiomas of the head and neck[J].Head Neck, 2011, 33(11):1649-1655.DOI:10.1002/hed.21552.
[14] Cheng J.Doxycycline sclerotherapy in children with head and neck lymphatic malformations[J].Journal of Pediatric Surgery, 2015, 50(12):2143-2146.DOI:10.1016/j.jpedsurg.2015.08.051.
[15] Markovic JN, Nag U, Shortell CK.Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children[J].J Vasc Surg Venous Lymphat Disord, 2020, 8(6):1074-1082.DOI:10.1016/j.jvsv.2019.11.023.
[16] 杨耀武, 郑家伟, 孙沫逸, 等.聚桂醇硬化剂治疗口腔颌面部血管瘤和脉管畸形专家共识[J].中国口腔颌面外科杂志, 2018, 16(3):275-278.DOI:10.19438/j.cjoms.2018.03.017.Yang YW, Zheng JW, Sun MY, et al.Expert consensus on the treatment of oral and maxillofacial hemangiomas and vascular malformations by lauromacrogol sclerotherapy[J].China J Oral Maxillofac Surg, 2018, 16(3):275-278.DOI:10.19438/j.cjoms.2018.03.017.
[17] Bai T, Liu Y, Jiang W, et al.A Review of sclerosing foam stability in the treatment of varicose veins[J].Dermatol Surg, 2020, 46(2):249-257.DOI:10.1097/dss.0000000000002039.
[18] Shergill A, John P, Amaral JG.Doxycycline sclerotherapy in children with lymphatic malformations:outcomes, complications and clinical efficacy[J].Pediatric Radiology, 2012, 42(9):1080-1088.DOI:10.1007/s00247-012-2406-2.

Memo

收稿日期:2021-04-09。
基金项目:上海市儿童医院临床研究培育专项重点项目(2020YLYM02)
通讯作者:陈舟,Email:chenz@shchildren.com.cn

Last Update: 1900-01-01